Good to see a continuous disclosure from the company, here are some points from today presentation that have come to my attention:
(my highlighting)
....plus...:
"The presentation will be used to update shareholders, investors and strategic partners on the ongoing Phase 1b and Phase 2 clinical trials, pipeline products in development and other key upcoming activities."
....looking forward to more specific news.
Ann: Updated Investor Presentation, page-32
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
0.008(2.38%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $624.4K | 1.958M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 440962 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 515755 | 15 |
View Market Depth
| Last trade - 13.40pm 22/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
